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ABSTRACT 
Two simple, quick and sensitive methods were described for the spectrophotometric determination of Gemifloxacin 
mesylate (GFX) either in pure form or in  the Pharmaceutical form. The methods were based on the reaction of GFX 
as ‘n’ electron donor with Chloranilic acid(CLA) and Parachloranil(CL) as π acceptors to give highly coloured 
complex  species. The coloured products were quantitated spectrophotometrically at 530nm and 540nm at zero 
order, 590and 610nm for the first derivative and 630and 650nm for second order derivative. Optimization  of the 
different experimental conditions were described. Beer’s law was obeyed in the concentrations range of 
10to60µg/ml, 5to25µg/ml at zero order,5to 25µg/ml, 5to40µg/ml at first order  and 2to20µg/ml and 2to 14µg/ml at 
second order. The limit of detection and quantification were calculated and relative standard deviation (RSD) for 
different concentrations of GFX using various acceptors were less than 0.128  %.The association constant of 1:1 
complexes and Standard free energy changes were studied. The proposed methods were successfully applied to the 
determination of GFX in pharmaceutical dosage form without interference from common additives encountered. 
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INTRODUCTION TO GEMIFLOXACIN 
Gemifloxacin (GMF) chemically R,S-7-(3 amino methyl 4- syn methoxyimino-1pyrrolidinyl)-1cyclopropyl-6-
flouro1,4,dihydro 4- oxo-1,8 napthyridine-3-carboxylic acid methane- sulphonate[1-3] is a new flouroquinolone 
antibacterial compound with enhanced affinity  for bacterial topoisomerase-IV and is being used for the treatment  
of  respiratory and urinary tract infections.[4-6]. Literature review revealed few analytical methods for the 
determination of GMF include HPLC, electrophoresis, UV-spectrophotometry concerning visible 
spectrophotometry. very few methods have been reported and no derivative spectrophotometry has been reported, 
hence sensitive and accurate ,direct, derivative spectrophotometric method has been viewed[7-10].The molecular 
interaction between electron donor and electron acceptor generally  associated with formation of intensely coloured 
charged complexes(Ion paired complexes) had absorbed radiation in visible region [11]. The photometric methods 
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based on these interactions were usually simple and convenient because of the rapid formation of complexes .GFX 
is a good ‘n’ electron donor and form ion pair complex with π acceptors such as Chloranilic acid(CLA) and Para 
chloranil(CL) and known to yield ion pair complexes and radical anions with variety of electron donor[12-22]. This 
donor acceptor interactions has been investigated, GFX as electron donor. The present study describes direct simple, 
more sensitive and precise spectrophotometric methods than the existing U.V and HPLC methods that were free 
from experimental variables such as extraction steps. No interference was observed in the assay of GFX from 
common excipients in levels used in the pharmaceutical formulations. The reaction conditions and application of the 
method for the determination of GFX in Tablets have been established. In addition the association constant, the 
stiochiometric ratio of reactants and standard free energy changes were determined. 
EXPERIMENTAL 
APPARATUS: All absorption spectra were made using SCIMADZU U.V 160spectrophotometer equipped with 
10mm matched Quartz cells. 
MATERIALS AND REAGENTS: All reagents and solvents were of Analytical grade(AR grade) 
The following commercial formulations were subjected to the Analytical procedures 
1.Gemez(Majesta) a division of Glenmark Pharmaceuticals Ltd, Mumbai, labeled to contain 320mg of GFX 
2. G.cin(Hetero drugs Ltd, Hyderabad, labeled to contain 320mg of GFX were used. 
STOCK SOLUTIONS:  Stock solutions of GFX were prepared by dissolving 40mg and 10 mg in 5ml of distilled 
water and volume was made up to mark in a100ml calibrated volumetric flask with distilled water to obtain the stock 
solution of 1x10-
3M and 0.1mg/ml of drug. Such drug solutions were stable for about 3days when stored in 
refrigerator at 5
oc 
Chloranilic acid (CLA) and P-Chloranil(CL)  were freshly prepared as 1x10
-2 M solution in acetonitrile .The 
solution was stable for greater than one week at 5
oc  
GENERAL PROCEDURES: To a 10ml volumetric flask transferred 1ml of 1x10
-3M GFX stock solution and 2ml of 
1x10
-2M CLA or CL reagents were added .The reaction mixture was heated on a water bath at 60±2
o C for 10min for 
CLA or CL methods. After cooling and diluting to volume with acetonitrile, the absorbance was measured at 530nm 
and 540nm for CLA and CL respectively against a reagent blank prepared in the same manner. 
PROCEDURE FOR DOSAGE FORM: An accurately weighed amount of finely powdered tablet  equivalent to 
100mg of drug was dissolved in about 20ml of distilled water and transfered into a 100ml calibrated volumetric 
flask and after 30 min of mechanical stirring was   filtered into a 100ml calibrated volumetric flask through 
Whatmann No:41 filter paper necessary amounts of filtrate was diluted to 100ml with acetonitrile and then the same 
procedure is followed as described above. 
STIOCHIMETRIC RELATIONSHIP: Job’s method for continuous variation[23] was employed to establish the 
stiochiometry of coloured products. A 1x10-
3M concentration standard solution of GFX and 1x10
-3M concentration 
solution of CLA and CL were used .The absorbance of the complex was used to calculate the association constants 
and standard free energy changes of complexation(ΔG). 
RESULTS AND DISCUSSIONS  :   
The interaction of GFX with CLA and CL in acetonitrile yielded red coloured chromgen absorbing maximally at 
wavelength 530nm and 540nm respectively (Fig:2) Most propably due to the formation of charge transfer complexes 
between GFX acting as n-donor(D) or Lewis base and CLA and CL act as π acceptor(A) or Lewis acid. 
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Fig-1 Absorption spectra of 40µg/ml GFX complex with 1x10 
-2-M CLA and CL respectively against reagent blank. 
 
Fig2: First order derivative of 40µg/ml GFX complex with 1x10 
-2-M CLA  and CL 
The dissociation of the DA complex was promoted by the high ionizing power dielectric constant of acetonitrile 
solvent,[24], further support for the assignment was provided by the comparison of  the  absorption bands with those 
of the CLA
.-and CL
.- radical anions produced in acetonitrile 
OPTIMUM CONDITIONS 
1)  CHOICE OF THE SOLVENT: Although charge transfer complexes are propably formed in many solvents 
the high cut of points of some solvents observed short wavelengths and therefore  clear cut spectroscopic 
evidences for charge transfer complexes could not be ascertained. Acetonitrile is found to be the best 
solvent for the two reagent because it has high relative permittivity which yielded maximum of CLA
. and 
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CL
. species . Other solvents such as Ethanol, Chloroform, Methylene chloride and 1,4 –Dioxane were also 
examined as possible substitutes but the colour intensity was lower with these solvents.(Table-1) 
Table-1 Effect of  solvent on the absorption intensity of the reaction products of GFX with CLA and CL 
Solvent  Absorbance CLA(530nm)  Absorbance CL(540nm) 
Acetonitrile 
Chloroform 
Ethanol 
1,4Dioxane 
0.814 
0.016 
0.026 
0.022 
0.515 
0.01 
0.023 
0.002 
 
2)  REAGENT CONCENTRATION : When the various concentrations of CLA and CL were added to a fixed 
concentration of GFX, 2ml of 1x10
-2M solution of CLA or CL found to be sufficient for the production of 
maximum and reproducible colour intensity (Fig-3). Higher concentrations of  reagents did not effect the 
colour intensity. 
 
Fig-3  Second order derivative of 40µg/ml GFX complex with 1x10 
-2-M CLA and CL 
3)  REACTION TIME: The optimum reaction time was determined by the following colour development at 
room temperature ( 25±2 
0C). Complete colour development was not attained till 60 minutes, after heating 
on waterbath at 60±2
0C for 10 minutes for CLA and CL. The colour  remain stable  for ≥ 36 hours for the 
two reagents. 
4)  STICHIOMETRIC OF THE REAGENTS : The stichiometric ratio of the reagents ( drug: reagent) in the 
charge transfer complex was determined by the method of continuous variation(Job’s method) was found to 
be 1:1 for CLA and CL (Fig-4).This suggests that one Nitrogen atom of the piperidine ring in GFX is 
involved in the reaction with CLA and CL. 
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Fig-4 Effect of reagent concentration(1x10
-2M)on the formation of GFX complex with CLA and CL 
Table-2Statastical Analysis of Calibration graphs and analytical data for the complexation of GFX with CLA and CL methods 
Parameter GFX-CLA 
 
GFX-CLA 
    Ist 
derivative 
GFX-CLA 
2
nd 
derivative 
GMF-CL 
 
GMF-CL 
Ist  
derivative 
GMF-CL 
2
nd 
derivative 
Wavelength גּ -  max   
Temperature 
Time   
Linearity range(µg/ml) 
Molar absorptivity € 
LOD(mcg/ml) 
LOQ(mcg/ml) 
Slope 
Intercept 
Correlation coefficient 
Accuracy 
RSD% 
530nm 
60
0C 
10min 
5-25 
1.165x10
5 
1.2 
3.95 
0.011 
0.001 
0.997 
100.03 
0.324 
590nm 
60
0C 
10min 
5-40 
4.875x10
4 
0.9 
2.73 
0.004 
0.001 
0.999 
100.15 
0.096 
630nm 
60
0C 
10min 
2-20 
9.12510
4 
0.7 
2.35 
0.008 
0.002 
0.998 
100.3 
0.106 
540nm 
60
0C 
10min 
10-60 
1.025x10
5 
1.5 
5.2 
0.011 
0.01 
0.996 
100.01 
0.0089 
610nm 
60
0C 
10min 
5-50 
5.6x10
4 
1.1 
3.8 
0.006 
0.002 
0.999 
100.05 
0.0107 
650nm 
60
0C 
10min 
2-14 
9.7x10
4 
0.9 
2.73 
0.009 
0.001 
0.999 
100.1 
0.1289 
 
5)  ASSOCIATION CONSTANT AND FREE ENERGY: By  using job’s method it was found that 1:1 
complex  was found and K the Association constant was calculated based on the formula:           
                     K=1-α/α
2 X C           where α =O.Dmax-O.Dmin/O.Dmax 
                                                         And C is the Concentration. 
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          The calculated association constants were recorded in Table-3 .The low values obtained are common 
in these complexes due to the dissociation of the original donor-acceptor complex to the radical anion. 
Table 3: Stability constants of Gatifloxacin mesylate chelate with CLA and CL byJob’s    method 
 
Parameters  GMF-CLA at 530nm  GMF-CL at 540nm 
Total molar conc 
N   
A/Aex             
β* 
Logβ 
ΔG
0 
1x10
-4M 
2.303 
1.0714 
2.156x10
5 
5.34 
-3.9 
1x10
-4M 
2.303 
1.11 
9x10
6 
6.954 
-3.99 
The standard free energy changes of complexation (ΔG
0) were calculated from the association constants by 
the following equation[25] 
                                                ΔG
0 = 2.303RT Log K  
where ΔG
0 is the free energy change of the complex (KJ mol-
1),R is the gas constant(1.987cal mol
-1deg
-1) 
,T is the temperature in Kelvin(273+000
0C) K is the Association constant of the drug-acceptor complex 
(1mol
-1) 
6)   INTERERENCE STUDY: Potential interference by the excipients in the dosage form was also studied 
samples were prepared by mixing fixed amounts of common excipients such as lactose, microcrystalline 
cellulose, talc, magnesium sterate and starch. The good percentage recoveries (Table-4) were obtained 
indicating no interference was observed from any of these excipients with the prepared method. The 
absence of interference from these excipients was attributed to the extraction with organic solvents prior to 
analysis. 
Table 4: Determination of  Gemifloxacin  in presence of common excipients 
                      Recovery±%RSD 
Excipient             GFX-CLA 
             530nm   
         GFX-CLA 
            540nm 
Microcrystallinecellulose 
Lactose(10mg) 
Talc(10mg) 
Magnesium sterate(10mg) 
Starch(10mg) 
100.05±0.1257 
100.03±0.159 
100.01±0.177 
99.9±0.137 
100.01±0.157 
100.01±0.1343 
99.8±0.1 
99.9±0.124 
99.95±0.15 
100.03±0.1699 
 
7)  QUANTIICATION: Commercial formulations of GFX   were successfully analysed by the proposed 
methods. The reliability of the proposed method was checked by standard addition method. The results 
(Table-5) show that the mean recoveries were found in the range of 100.01-100.03 with RSD≤ 0.0687   % 
for CLA and 100.01 with RSD≤ 0.00578   for CL. The performance order of the proposed methods is CLA 
> CL. 
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Fig-5 Job’s method for GFX complex with CLA and CL;גּ-530nm,540nm,respectively. 
 
 
Table-5 Results of analysis of Tablet formulations containing GFX 
Formulation  Labelled amount  % Recovery 
CLA 
%Recovery  CL  %RSD            
CLA                    
%RSD             
CL 
Gemez 
G-cin 
320mg 
320mg 
100.03 
100.01 
100.01 
100.01 
0.0687 
0.01117 
0.003726 
0.005773 
 
ISSN : 0975-9492 228D.Madhuri et. al. / International Journal of Pharma Sciences and Research (IJPSR) 
Vol.1(4), 2010, 222-231 
Table-6 Determination of GFX in Pharmaceutical dosage forms applying standard addition technique 
Proposed method  Taken µg/ml  Added µg/ml  Gemez  G-cin 
CLA 
 
 
 
 
 
Mean 
%RSD 
 CL 
 
 
 
 
 
 
Mean 
%RSD 
40 
 
 
 
 
 
 
 
 
40 
 
 
40 
80 
120 
160 
200 
 
 
 
-- 
40 
80 
120 
160 
200 
 
 
100.03 
99.8 
100.02 
100.02 
100.03 
100.02 
99.98 
0.08361 
 
100.02 
99.8 
100.02 
100.04 
100.01 
100.03 
99.98 
0.0839 
100.01 
99.6 
99.8 
100.03 
100.04 
100.02 
99.91 
0.1639 
 
100.01 
100.03 
99.9 
99.8 
100.03 
100.02 
99.97 
0.0865 
 
CONCLUSION   : The proposed methods are simple ,less time consuming and more sensitive and validated than the 
reported U.V and HPLC methods. The proposed method concerning CLA is superior to CL. The proposed methods 
are suitable for the determination of GFX in pharmaceutical formulation without interference from excipients 
suggesting useful applications in bulk analysis. 
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